FUL vs LIN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
H.B. Fuller exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust operational efficiency. While the current price of $62.83 sits above the Graham Number ($49.65), it remains well below the growth-based intrinsic value of $85.26. The company is experiencing a divergence between declining revenue (-2.30%) and surging earnings growth (58.30%), suggesting significant margin expansion or cost optimization. Despite a bearish technical trend, the attractive forward P/E of 12.22 and analyst buy ratings support a positive outlook.
LIN shows neutral fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Mixed signals with both opportunities and risks present.
Compare Another Pair
Related Comparisons
FUL vs LIN: Head-to-Head Comparison
This page compares H.B. Fuller Company (FUL) and Linde plc (LIN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.